When the Buyer Cannot Picture Themselves Six Months In, the Deal Will Not Move

The Demo Went Well. Then She Went Silent.

The CFO of a mid-market financial-services firm sat through a forty-five-minute product demo. The seller did the walkthrough. The CFO asked clarifying questions about integration timeline and data residency. She nodded at the right places. She said the platform looked promising. She agreed to receive the proposal.

The seller hung up thinking the deal was close.

It was not close.

What the CRM did not capture

The CRM logged the call as a successful demo. The next-step field said "send proposal." The probability ticked up from sixty percent to seventy-five percent. The forecast for the quarter improved. The VP of Sales did not flag the account in his Friday review.

The CFO went silent for four weeks.

The proposal was opened twice and never returned to. The follow-up emails from the rep moved into a folder she did not check. The internal Slack channel where she had been asking her ops team about the project went quiet. The deal that was at seventy-five percent in the CRM was at zero percent in her head.

What she was actually doing

She was not waiting on more information. She had the integration documents, the security review, the three references she had requested. She was running the install in her head, trying to picture her finance team six months from now using the platform every day, and she could not see it.

She could not see what her team's Tuesday looked like in the new state. She could not see the failure modes. She could not see the report she would be running at the next board meeting to prove the spend was worth it.

The deal was not in evaluation. The deal was in a different stage entirely, and her CRM did not have a field for it.

The Question Every B2B Buyer Asks Silently

Every B2B buyer runs a silent question through every late-stage purchase decision. The methodology playbook does not name it. The discovery script does not surface it. The CRM cannot track it.

The question is: if I buy this and it does not work, what happens to me?

Not to my company. To me. Personally.

Why methodologies miss this

The major B2B sales methodologies were built to handle objections the buyer voices:

• MEDDIC qualifies budget, decision criteria, decision process.

• BANT asks about budget, authority, need, timing.

• Challenger reframes the conversation with commercial insight.

• SPIN uncovers needs through structured questioning.

Each one assumes the buyer is willing to surface what is blocking the decision. Each one is excellent inside that assumption.

The unspoken question violates the assumption. It is the question the buyer is the most committed to never voicing, because voicing it sounds unprofessional. It sounds like fear. It sounds like the kind of question a junior employee asks, not a CFO making a five-hundred-thousand-dollar commitment that will end up on her own performance review.

So the buyer does not ask it. The seller cannot answer it. The deal dies in a silence the rep mistakes for evaluation.

The diagnosis lives in a dimension your pipeline does not measure

The dimension is Outcome Confidence. It is the buyer's settled belief that the specific outcome she needs will actually arrive, in a form she can recognize, on a timeline she can defend, given her organization's specific constraints.

She is not waiting on information. She is waiting on a mental movie.

Three Uncertainties, Not One

Germeijs and De Boeck identified three distinct factors that produce decision indecision (Germeijs & De Boeck, Journal of Vocational Behavior, 2003). The framework was developed for career decisions and has since been confirmed in B2B sales data across more than two million recorded conversations.

The three types do not respond to the same intervention:

• Valuation uncertainty. "I cannot tell whether this is worth what they are asking." Addressed by pricing conversation, ROI calculation, business-case framing.

• Information uncertainty. "I do not have enough specifics yet." Addressed by demos, technical documentation, reference calls.

• Outcome uncertainty. "I cannot picture how this works in my world six months from now." Addressed by nothing your current sales motion is built to deliver.

Most B2B sales playbooks are built almost entirely around the first two. The third one is the orphan dimension.

Why the orphan matters

Buyer trust in the supplier significantly reduces decision-making uncertainty in B2B purchasing relationships (Gao, Sirgy & Bird, Journal of Business Research, 2005). The mechanism the literature documents is not that trust replaces information. Trust replaces the cost of running the mental simulation alone. A buyer who trusts the supplier offloads part of the future-state simulation onto the supplier's track record. A buyer who does not trust the supplier has to run the entire future-state simulation in her head, by herself, and she will not run it to completion before the quarter ends.

That is the silent stall.

Why Proof Points Alone Are Not Enough

The reflex when a deal goes silent is to send more proof. Another case study. Another reference. Another technical document. The rep believes the buyer is stuck on information and proof closes information gaps.

Sometimes the proof works. Most of the time, the proof bounces off.

The reason is that trust itself decomposes (Johnson & Grayson, Journal of Business Research, 2005) into two empirically distinct dimensions:

• Cognitive trust. Competence-based, evidence-driven. Earned through proof points, case studies, references, security reviews. This is what your current sales motion is built to produce.

• Affective trust. Relationship-based, intuition-driven. Earned through the buyer's lived sense that the seller understands her specific situation, that the seller has been in her chair, that the seller will not disappear after the contract is signed.

Most deals that fail in Outcome Confidence have cognitive trust at a high level and affective trust at a low level. The buyer believes the product works. She does not yet believe it will work for her.

Sending her another case study addresses the dimension she already trusts. It does not address the dimension she does not yet trust.

The shape of the mistake

The cognitive-trust reflex shows up in a recognizable pattern:

• The rep sends three references in week one of the proposal stage.

• The buyer asks for two more.

• The rep sends them.

• The buyer goes quiet for two weeks.

• The rep escalates to the VP of Sales. The VP sends a personal note offering a fourth reference.

• The buyer schedules the call, listens politely, and goes silent again.

Each reference call addresses cognitive trust. None addresses affective trust. The deal stalls in a loop that looks like evaluation and is actually a different process entirely.

What a Buyer Without Outcome Confidence Is Actually Doing

This is the part the dashboard cannot show.

The mental movie

The CFO sits at her desk with the proposal open in one window and her calendar in another. She is not reading the proposal. She read it three days ago. She is staring at it because the staring is what the running of the mental movie looks like from the outside.

In the movie, she is sitting in the same chair six months from now. The platform is installed. The team is using it. She is about to present the quarterly results to the board.

She cannot see the slide.

She cannot see what number she is reporting. She cannot see what the comparison to the prior quarter looks like. She cannot see her CFO peer at the next firm asking how she made the case for the investment. She cannot see the moment of vindication the purchase was supposed to deliver.

She closes the proposal. She tells herself she will look at it again on Monday. On Monday she has three other priorities. The deal does not move.

Why brands matter in the silence

Brown and colleagues, in field studies of more than three hundred organizational buyers, found that B2B brands serve as risk-reduction heuristics with a U-shaped relationship to purchase risk (Brown et al., 2011). Brand sensitivity peaks at both the lowest-risk and highest-risk ends of the curve, for different reasons. At the highest-risk end, where Outcome Confidence is the binding constraint, the buyer leans on the brand to substitute for the mental simulation she cannot complete on her own.

The challenger vendor without the brand has to deliver the simulation directly. The incumbent with the brand has the simulation pre-delivered by the buyer's existing mental model of the company.

This is why brand work matters in late-stage B2B deals even when the rep would swear the deal is "all about features and price." The features and price were settled in week two. The simulation is still running in week eight.

The Highest-Impact Behavior in B2B Sales (and Almost Nobody Does It)

Dixon and McKenna's research at Tethr, drawn from analysis of more than 2.5 million B2B sales conversations, identified the single behavior that produces the largest improvement in win rate (Dixon & McKenna, Harvard Business Review, 2022):

• Setting outcome expectations early and explicitly improves win rates by 155 percent.

• This behavior appears on only 19 percent of sales calls.

That gap is the largest one in their dataset. The single most impactful seller behavior is also the most underused.

What "setting outcome expectations" actually means

The behavior is not a closing tactic. It is not an assumptive close. It is not the "vision call" some methodologies prescribe at the end of the cycle.

The behavior is the seller saying, early, what the buyer will be looking at six months in:

• The specific report she will be running.

• The specific peer she will be comparing notes with.

• The specific stakeholder who will be asking her if the investment paid off.

• The specific risk the investment will have eliminated.

This is the mental movie the buyer is trying to run, delivered by the seller, before the buyer has to run it alone in silence.

The reason eighty-one percent of reps skip it is that it requires a kind of specificity most sales training does not teach. It requires having watched the customer succeed in a specific role at a specific company size on a specific timeline. It is the work of the experienced operator, not the new rep with the playbook.

That is why the lift is so large and the usage rate is so low.

Three Diagnostic Moves to Surface Outcome Confidence

The hard part of fixing an Outcome Confidence problem is seeing it in the pipeline before the deal goes silent. These three moves surface it in time to act.

The pipeline-review question

In the next Friday pipeline review, ask the rep one question for every late-stage deal:

What is the buyer picturing six months in?

If the rep cannot answer, the deal is not in evaluation. The deal is in invisible-stall.

The rep's answer should include:

• The specific report or dashboard the buyer will be running.

• The specific stakeholder who will be asking about the investment.

• The specific competitor or peer the buyer will be benchmarking against.

If the rep can only describe what the product does, the buyer cannot picture using it.

The Tuesday-at-month-four question

In the next live call with the buyer, ask her to walk you through a Tuesday at month four post-purchase.

Not a quarterly review. A Tuesday. A normal day.

Listen for:

• Whether she names a specific time of day she would use the platform.

• Whether she names a specific colleague she would ask for help.

• Whether she names a specific output she would generate.

• Whether she names a specific moment of friction the platform would resolve.

A buyer with Outcome Confidence answers in concrete detail. A buyer without Outcome Confidence answers in abstractions or changes the subject.

The reference replacement

In the proposal stage, replace the third reference call with an outcome-specific simulation:

• Build a one-page mock of the report the buyer will be running at her next board meeting six months in.

• Use her actual current metrics as the starting point.

• Show her, on paper, what the comparison looks like.

Buyers do not need more case studies in the late stage. They need to see themselves in the case study. The mock is not a sales asset. The mock is a delivery of the mental movie she has been trying to run alone.

If she rejects the mock as inaccurate, you have not lost the deal. You have surfaced the gap between her actual picture of success and your read of her picture of success. Closing that gap is now the work. That work moves the deal. More references will not.

A Different CFO. A Different Deal. The Same Question Asked Earlier.

Two quarters later, a different CFO at a different firm sits through a forty-five-minute demo. The seller does the walkthrough. The CFO asks clarifying questions.

This time the seller asks a different question early.

He asks her, in week one, what the report on her desk would look like six months from now if the platform worked. He listens. He pushes back when she answers in generalities. He writes down the specifics she does give him.

In week two he sends her the one-page mock.

She emails back the same day with three corrections to the mock. The corrections show him what she actually cares about. They also show her she cares about something specific, which is the moment the mental movie starts to play in her head with sound.

The deal closes in twenty-eight days.

The product was the same product. The pricing was the same pricing. The reference customers were the same reference customers. The thing that changed was that the seller asked, early, the question the buyer was running silently and the methodology had not named.

Most of the deals stalling in your pipeline right now are stalling on the same dimension. The cognitive trust is in place. The affective trust is not. The mental movie is incomplete. The buyer is sitting at her desk staring at a proposal because the staring is what the missing simulation looks like from the outside.

If your last ten closed-lost deals contain three or more where the buyer "went dark" after a demo that "went well," your pipeline has an Outcome Confidence problem. Take the four-minute Readiness Check to score your category against the four buyer-readiness dimensions. Outcome Confidence is the third one. You will know which dimension is breaking first, which is the diagnosis. The plan for the quarter follows the diagnosis. The diagnosis does not follow the plan.

The connection back to the buyer readiness gap sits underneath this entire post. Buyer readiness asks whether the buyer has completed the four internal decisions that make a purchase possible. Outcome Confidence is the decision the methodology cannot see and the dashboard cannot measure. Most of the fifty-six percent of qualified deals that die in no-decision die here, in the silence between a successful demo and a proposal that never gets returned to. The fix is not more proof. The fix is a different conversation, asked earlier, about a future state the buyer is already trying to picture and cannot.

That is the work of the next pipeline review. Not the next demo. Not the next reference. The next conversation, with the buyer who is staring at your proposal, about the cost she is paying in silence while the mental movie refuses to play.